Back to Trades
GROGAN DONNA ROY
DirectorCIK 0001788455
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
GROGAN DONNA ROY, Director, has filed 6 SEC reports (2025–2026), all concentrated in C4 Therapeutics, Inc. (CCCC), totaling $336.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Oct 2 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Grant | $14.5K |
| Jul 2 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Grant | $14.5K |
| Jun 26 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Award | $263.5K |
| Apr 3 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Grant | $14.5K |
| Jan 5 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Grant | $14.5K |
| Oct 3 | CCCC C4 Therapeutics, Inc. | GROGAN DONNA ROY | Director | Grant | $14.5K |
6 filings